Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

1(20.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 1(1)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07131293Recruiting

European Registry Study on Lymphatic Interventions

Role: collaborator

NCT03017326Phase 3Active Not Recruiting

Paediatric Hepatic International Tumour Trial

Role: collaborator

NCT01701479Phase 1Unknown

Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Role: collaborator

NCT01838447Phase 2Completed

Prevention of Vitamin D Deficiency Following Pediatric CHD Surgery: a Phase II Dose Evaluation Randomized Controlled Trial Comparing Usual Care With a High Dose Pre-operative Supplementation Regimen Based on the Institute of Medicine Daily Upper Tolerable Intake Level

Role: collaborator

NCT01804855Not ApplicableUnknown

Effectiveness of a Smartphone App for Adolescent Obesity Management

Role: lead

NCT02218632Not ApplicableCompleted

Glycosylation in Patients With Galactosaemia

Role: lead

All 6 trials loaded